Peritonealdialyseschaltung

EP4292623 Art B8 3. Dezember 2025

Anmelder: Vantive Health GmbH, Vantive US Healthcare LLC, BAXTER HEALTHCARE SA, Baxter International, Inc. 🇨🇭

Details

Veröffentlichungs-Nr.
EP4292623
Aktenzeichen
EP22179556
Anmeldetag
17. Juni 2022
Veröffentlichung
3. Dezember 2025
Erteilung
3. Dezember 2025
Rechtsraum
EP
IPC
A61M1/28
Offizieller Volltext

Abstract

A peritoneal dialysis fluid circuit comprising a patient line, a delivery line configured to supply fresh dialysis fluid towards the patient line, a withdrawal line configured to withdraw spent dialysis fluid from the patient line, a first pump arranged on the delivery line and configured to supply fresh dialysis fluid towards the patient line, and a second pump arranged on the withdrawal line and configured to withdraw spent dialysis fluid from the patient line. The fluid circuit further comprises a control unit configured to perform a peritoneal dialysis procedure. The peritoneal dialysis procedure comprises commanding activation of the first pump at a first flow rate, and activation of the second pump at a second flow rate different from the first flow rate: the first pump and the second pump are active simultaneously to provide the first flow rate and the second flow rate.

Anmelder

Firmen
Vantive Health GmbH
Vantive US Healthcare LLC
BAXTER HEALTHCARE SA
Baxter International, Inc.
Land
🇨🇭 Schweiz
🇺🇸 Baxter International

US-amerikanisches Medizintechnik- und Gesundheitsunternehmen mit Sitz in Deerfield, Illinois, gegründet 1931. Produkte umfassen Dialysesysteme, Infusionstechnik und Injektionslösungen.

1.268 Patente in unserer Datenbank

Noch Fragen?

Wir helfen Ihnen gerne weiter. Schreiben Sie uns einfach.

Kontakt aufnehmen